WuXi XDC Cayman Inc
HKEX:2268
WuXi XDC Cayman Inc
Operating Income
WuXi XDC Cayman Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Operating Income
¥147.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Operating Income
¥10.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Operating Income
¥1.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Operating Income
¥4.1B
|
CAGR 3-Years
36%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Operating Income
¥1.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
25%
|
CAGR 10-Years
32%
|
|
Genscript Biotech Corp
HKEX:1548
|
Operating Income
-$387.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is WuXi XDC Cayman Inc's Operating Income?
Operating Income
147.8m
CNY
Based on the financial report for Dec 31, 2022, WuXi XDC Cayman Inc's Operating Income amounts to 147.8m CNY.
What is WuXi XDC Cayman Inc's Operating Income growth rate?
Operating Income CAGR 1Y
116%
Over the last year, the Operating Income growth was 116%.